Mehadrin (MEDN) — Capital Reinvestment Ratio
Latest as of June 2025:
0.04x
Mehadrin (MEDN) has a Capital Reinvestment Ratio of 0.04x as of June 2025, meaning it reinvests 0% of its operating cash flow (ILA68.11 Million) in capital expenditures (ILA2.39 Million). See Mehadrin (MEDN) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
ILA68.11 Million
ILA
Capital Expenditures
ILA2.39 Million
ILA
Data as of
Jun 2025
Most recent filing
Mehadrin Capital Reinvestment Ratio (2007–2023)
This chart tracks Mehadrin's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Mehadrin (2007–2023)
Year-by-year Capital Reinvestment Ratio for Mehadrin from 2007 to 2023. For live market cap and broader valuation context, see Mehadrin (MEDN) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 4.00x | ILA3.99 Million | ILA15.99 Million | ▲ +357.9% |
| 2020 | 0.87x | ILA21.74 Million | ILA19.01 Million | ▲ +1.9% |
| 2019 | 0.86x | ILA38.35 Million | ILA32.92 Million | ▼ -16.8% |
| 2018 | 1.03x | ILA41.61 Million | ILA42.95 Million | ▲ +145.0% |
| 2017 | 0.42x | ILA89.56 Million | ILA37.73 Million | ▲ +22.7% |
| 2016 | 0.34x | ILA56.89 Million | ILA19.53 Million | ▲ +97.1% |
| 2015 | 0.17x | ILA64.25 Million | ILA11.19 Million | ▼ -18.8% |
| 2014 | 0.21x | ILA80.06 Million | ILA17.17 Million | ▼ -60.4% |
| 2013 | 0.54x | ILA57.63 Million | ILA31.23 Million | ▼ -25.3% |
| 2012 | 0.73x | ILA72.44 Million | ILA52.54 Million | ▼ -24.4% |
| 2010 | 0.96x | ILA33.92 Million | ILA32.55 Million | ▲ +176.0% |
| 2009 | 0.35x | ILA85.78 Million | ILA29.82 Million | ▼ -90.2% |
| 2008 | 3.53x | ILA11.53 Million | ILA40.73 Million | ▲ +712.5% |
| 2007 | 0.43x | ILA74.22 Million | ILA32.26 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow